Causes of death within 1 year of resection for lung cancer. Early mortality after resection

European Journal of Cardio-thoracic Surgery

Volumn 25, Issue 4, 2004, Pages 515-519

  Toker, Alper ^a   Dilege, Sukru ^a   Ziyade, Sedat ^a   Eroglu, Osman ^a   Tanju, Serhan ^a,b   Yilmazbayhan, Dilek ^a   Kilicarslan, Zeki ^a   Kalayci, Goksel ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Lung cancer; Mortality; Surgery

Indexed keywords

ADULT; AGED; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARDIOPULMONARY HEMODYNAMICS; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOMA; LUNG RESECTION; LUNG SURGERY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1642357512     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2004.01.012     Document Type: Review

References (21)

1. Strauss G.M., Kwiatowski D.J., Harpole D.H., Lynch T.J., Skarin A.T., Sugarbaker D.J. Molecular and pathological markers in stage 1 non small cell carcinoma of the lung. J Clin Oncol. 13:1995;1265-1271.
2. Harpole D.H. Jr., Herndon J.E. II, Young W.G. Jr., Wolf W.G., Sabiston D.C. Jr. Stage I nonsmall cell lung cancer: a multivariate analysis of treatment methods and patterns of recurrence. Cancer. 76:1995;787.
3. Tisi G., Friedmann P., Peters R., Pearso G., Carr D., Lee R., Selawry O., The American Thoracic Society. Clinical staging of primary lung cancer. Am Rev Respir Dis. 127:1983;659-664.
4. Goldman L. Cardiac risks and complications of non cardiac surgery. Ann Surg. 198:1983;780-888.
5. LoCicero J. III, Ponn R.B., Daly B.D.T. Surgical treatment of nonsmall cell lung cancer. Shields T.W., LoCicero J. III, Ponn R.B. General thoracic surgery. 2000;1311-1342 Lippincott Williams and Wilkins, Philadelphia, PA.
6. Mountain J.F. Revisions in the international staging system for staging lung cancer. Chest. 111:1997;1710-1717.
7. Handy J.R., Asaph J.W., Skokan L., Reed C.E., Koh S., Brooks G., Douville E.C., Tsen A.C., Ott G.Y., Silvestri G.A. What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest. 122:2002;21-30.
8. Naruke T., Goya T., Tsuchiya R., Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg. 96:1998;440-447.
9. Conill C., Astudillo J., Verger E. Prognostic significance of metastases to mediastinal lymph node levels in resected non small cell lung carcinoma. Cancer. 72:1993;1199-1202.
10. Silvestri G.A., Littenberg B., Colice G.L. The clinical evaluation for detecting metastatic lung cancer. A meta-analysis. Am J Respir Crit Care. 152:1995;225-230.
11. Hillers T.K., Sauve M.D., Guyatt G.H. Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer. Thorax. 49:1994;14-19.
12. Port Meta-Analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet. 352:1998;257.
13. Le Chevalier T. Results of the Randomized International Adjuvant Lung Cancer Trial (IALT): cisplatin-based chemotherapy (CT) vs no CT in 1867 patients (pts) with resected non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol. 22:2003;2.
14. Deslauriers J., Ferraro P. Late complications. Pearson F.G., Cooper J.D., Deslauriers J., Ginsberg R.J., Hiebert C.A., Patterson G.A., Urschel H.C. Thoracic surgery. 2000;189-207 Churchill Livingstone, Philadelphia, PA.
15. Kearney D.J., Lee T.H., Reilly J.J., DeCamp M.M., Sugarbaker D.J. Assessment of operative risk in patients undergoing lung resection: importance of predicted of pulmonary functions. Chest. 105:1994;753-759.
16. Wang J., Olak J., Ferguson M.K. Diffusing capacity predicys operative mortality but not long term survival after resection of lung cancer. Thorac Cardiovasc Surg. 117:1999;581-587.
17. Whittle J., Steinberg E.P., Anderson G.F., Herbert R. Use of medicare claims data to evaluate outcomes in elderly patients undergoing lung resection for lung cancer. Chest. 102:1991;729-734.
18. Romano P.S., Mark D.H. Patient and hospital characteristics related to in-hospital mortality after lung cancer resection. Chest. 101:1992;1332-1337.
19. Nugent A.M., Steele I.C., Carragher A.M., McManus K., MacGuigan J.A., Gibbons J.R., Riley M.S., Nicholls D.P. Effect of thoracotomy and lung resection on exercise capacity in patients with lung cancer. Thorax. 54:1999;334-338.
20. Larsen K.R., Swendsen U.G., Milman N., Brenoe J., Petersen B.N. Cardiopulmonary function at rest and during exercise after resection for bronchial carcinoma. Ann Thorac Surg. 64:1997;960-964.
21. Travis W.D., Linder J., Mackay B. Classification, histology, cytology, and electron microscopy. Pass H.I., Mitchell J.B., Johnson D.H., Turrisi A.T., Minna J.D. Lung cancer principles and practice. 2nd ed:2000;453-495 Lippincot Williams and Wilkins, Philadelphia, PA.